medline.ch Dermatologie Tumoren Anderes

	Predicting Postoperative Recurrence Using a Support Vector Machine for Patients With Esophageal Squamous Cell Carcinoma: Machine Learning Modeling Development and Validation Study. JMIR Cancer Xu MQ, Jiang ZS, Liao WY, Kang Y, Feng XY, Jiang K, Jiang Q, Cong ZZ, Luo J, Wu L, Shen Y, Wang FY. PMID: 41129793 [PubMed - indexed for MEDLINE]
	Concordance in Basal Cell Carcinoma Diagnosis. Building a Proper Standard Reference to Train Artificial Intelligence Tools. Skin Res Technol Silva-Clavería F, Serrano C, Matas I, Serrano A, Toledo-Pastrana T, Acha B. PMID: 41127892 [PubMed - indexed for MEDLINE]
	Chemoradiotherapy with or Without Anlotinib for Postoperative Lymph Node Recurrence of Esophageal Squamous Cell Carcinoma: A Real-World Observational Study. Drug Des Devel Ther Zhu J, Tong YS, Zhu WG, Wang WW, Ji FZ, Zhou XL. PMID: 41127366 [PubMed - indexed for MEDLINE]
	Oncologic and Functional Outcomes of T3 Glottic Squamous Cell Carcinoma Following Transoral Laser Microsurgery: A Retrospective Chart Review. J Otolaryngol Head Neck Surg Taylor V, Bogner E, Henley J, MacKay C, Rigby MH, Corsten M, Trites J, Taylor M. PMID: 41126803 [PubMed - indexed for MEDLINE]
	Real-world efficacy of PD-1 inhibitors in treating oesophageal squamous cell carcinoma (ESCAPE): protocol of a multicentre, real-world, observational, cohort study. BMJ Open Wang C, Xie Q, Miao Y, He W, Wang K, Liu G, Fang Q, Peng L, Chen Y, Zhou J, Lv J, Qi Y, Wang Q, Shi Q, Han Y, Leng X. PMID: 41125270 [PubMed - indexed for MEDLINE]
	Pan-immune-inflammation value predicts survival of patients with oesophageal squamous cell carcinoma receiving immunotherapy and chemoradiotherapy: a pooled analysis of two phase II trials. Ann Med Cheng X, Luo K, Gao Y, Wang R, Liu S, Li Q, Zhou S, Yang H, Chen B, Liu Q, Xi M. PMID: 41123456 [PubMed - indexed for MEDLINE]
	Lower, more frequent cisplatin dosing minimizes hearing loss in head and neck cancer. JCI Insight Fernandez KA, Chowdhury AS, Bonczkowski A, Allen PD, Campbell MH, Lee DS, Malhotra C, Page BR, Mulford DA, Ortiz CE, Santa Maria PL, Kullar P, Khan SA, Newlands SD, Schmitt NC, Cunningham LL. PMID: 41122972 [PubMed - indexed for MEDLINE]
	FAM83A is a prognostic biomarker for lung squamous cell carcinoma and correlated with immunoregulation. Sci Rep Peng C, Kong X, Hui Y, Yang X, Hou Y, Sheng W, Yuan J, Fei X, Wang K, Nian J, Yu W. PMID: 41120598 [PubMed - indexed for MEDLINE]
	Nanoliposomal Irinotecan in Combination With 5-Fluorouracil and Leucovorin for Advanced Head and Neck and Esophageal Squamous Cell Carcinoma After Prior Platinum-Based Chemotherapy or Chemoradiotherapy: A Multicenter Phase II Trial. Cancer Med Yang MH, Wu SY, Ho IW, Chiang NJ, Hsaio CF, Lin CY, Lien MY, Chang PM, Chen JH, Hsieh CY, Hong RL, Lee CT, Chen LT, Liu TW, Chiu CF, Bai LY. PMID: 41117518 [PubMed - indexed for MEDLINE]
	Retrospective analysis of multimorbidity, polypharmacy, and drug interactions on postoperative outcomes in oral squamous cell carcinoma patients. Clin Oral Investig Schmitz A, Reichardt C, Gierth J, Richter M, Mrosk F, Alfertshofer M, Knoedler L, Doll C, Hausmann F, Lee M, Kleikamp B, Rendenbach C, Heiland M, Koerdt S. PMID: 41114747 [PubMed - indexed for MEDLINE]
	Î³Î´ T cells and head and neck squamous cell carcinoma. Int Rev Cell Mol Biol Peng J, Qiu H, Bu LL, Wu Q. PMID: 41110901 [PubMed - indexed for MEDLINE]
	Comparison of efficacy and safety in two versus three cycles of neoadjuvant immunotherapy plus chemotherapy for esophageal squamous cell carcinoma. J Cardiothorac Surg Ye G, Pan G, Zhu X, Liu H, Geng G, Jiang J. PMID: 41107939 [PubMed - indexed for MEDLINE]
	Retrospective Analysis of CT-based Habitat Analysis for Predicting pCR and Survival of ESCC Treated by Neoadjuvant Chemoradiotherapy and Esophagectomy. Technol Cancer Res Treat Zhang S, Qi WX, Wang F, Zhang Y, Chen J, Zhao S. PMID: 41100689 [PubMed - indexed for MEDLINE]
	Immunotherapy combined with definitive chemoradiotherapy for locally advanced unresectable esophageal squamous cell carcinoma. Front Immunol Hong Y, Tan Q, Li Y, Yang B, Wu Y, Zhao L, Zhao Y, Chen Y, Zhu Z, Zhu X, Gu L, Jiang N. PMID: 41098719 [PubMed - indexed for MEDLINE]
	Revisiting Cutaneous Carcinogenic Risk From Ultraviolet Nail Polish Dryer Lamp Exposure. Photodermatol Photoimmunol Photomed Duong JQ, Ceresnie MS, Kohli I, Lim HW. PMID: 41094685 [PubMed - indexed for MEDLINE]
	Neoadjuvant camrelizumab combined with chemoradiotherapy and watch-and-wait strategy versus neoadjuvant chemoradiotherapy followed by surgery in locally advanced oesophageal squamous cell carcinoma: study protocol of a randomised controlled trial (PALACE-3). BMJ Open Wang X, Li C, Cao Y, Kang X, Leng X, Zheng Y, Zheng B, Guo W, Jing H, Han Y, Chen C, Li Y, Li H. PMID: 41093345 [PubMed - indexed for MEDLINE]
	Tislelizumab in conjunction with chemotherapy for the treatment of nasal metastasis from lung squamous cell carcinoma: a case report and literature review. Ther Adv Respir Dis Luo K, Dai L, Lin K, Zhang H, Pi K, Yang N, Gao Y, Yu J, Wu J, Xiao Q. PMID: 41090956 [PubMed - indexed for MEDLINE]
	Real-world outcomes after concurrent chemo-radiotherapy in patients with locally advanced esophageal and gastroesophageal junction cancer. Acta Oncol Mortensen HR, Hoffmann L, Nordsmark M, Thorsen LBJ, Møller DS. PMID: 41090491 [PubMed - indexed for MEDLINE]
	The utility of a dermoscopic 'bud-like appearance' combined with disease duration in differentiating keratoacanthoma from well-differentiated cSCC: A preliminary study. Medicine (Baltimore) Chen GY, Ren KM, Shu J, Li FZ. PMID: 41088711 [PubMed - indexed for MEDLINE]
	Pathological responses to neoadjuvant immunochemotherapy: implications for survival and recurrence in patients with locally advanced esophageal squamous cell carcinoma. J Transl Med Li Y, Hong Y, Tan Q, Xu Y, Zhou J, Yang B, Xiao G, Huang X, Gu L, Jiang M, Zhao Y, Chen Y, Zhu Z, Zhu X, Wu Y, Jiang N. PMID: 41088460 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 63595

Seite 1 von 3180

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung